These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 12461001)

  • 21. [Mutant prevention concentrations of fluoroquinolones for Staphylococcus aureus].
    Cui JC; Liu YN; Wang R; Liang BB; Pei F; Zheng ZJ
    Zhonghua Yi Xue Za Zhi; 2004 Nov; 84(22):1863-6. PubMed ID: 15631794
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antistaphylococcal activity of DX-619, a new des-F(6)-quinolone, compared to those of other agents.
    Bogdanovich T; Esel D; Kelly LM; Bozdogan B; Credito K; Lin G; Smith K; Ednie LM; Hoellman DB; Appelbaum PC
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3325-33. PubMed ID: 16048943
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel ciprofloxacin-resistant, nalidixic acid-susceptible mutant of Staphylococcus aureus.
    Piddock LJ; Jin YF; Webber MA; Everett MJ
    Antimicrob Agents Chemother; 2002 Jul; 46(7):2276-8. PubMed ID: 12069989
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [A study on the resistance of Staphylococcus aureus and the mechanisms of its resistance to fluoroquinolone].
    Lei Y; Gui X; Feng G
    Zhonghua Nei Ke Za Zhi; 2001 Mar; 40(3):176-9. PubMed ID: 11798575
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative activity of ozenoxacin and other quinolones in Staphylococcus aureus strains overexpressing the efflux pump-encoding genes mepA and norA.
    López Y; Tato M; Gargallo-Viola D; Cantón R; Vila J; Zsolt I
    Int J Antimicrob Agents; 2020 Sep; 56(3):106082. PubMed ID: 32659467
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased in vitro activity of the novel des-fluoro(6) quinolone BMS-284756 against genetically defined clinical isolates of Staphylococcus aureus.
    Schmitz FJ; Boos M; Mayer S; Jagusch H; Fluit AC
    J Antimicrob Chemother; 2002 Feb; 49(2):283-7. PubMed ID: 11815569
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of the tannic acid inhibitory effect against the NorA efflux pump of Staphylococcus aureus.
    Tintino SR; Oliveira-Tintino CD; Campina FF; Silva RL; Costa Mdo S; Menezes IR; Calixto-Júnior JT; Siqueira-Junior JP; Coutinho HD; Leal-Balbino TC; Balbino VQ
    Microb Pathog; 2016 Aug; 97():9-13. PubMed ID: 27057677
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Active antimicrobial efflux in Staphylococcus epidermidis: building up of resistance to fluoroquinolones and biocides in a major opportunistic pathogen.
    Costa SS; Viveiros M; Pomba C; Couto I
    J Antimicrob Chemother; 2018 Feb; 73(2):320-324. PubMed ID: 29126275
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro activities of mutant prevention concentration-targeted concentrations of fluoroquinolones against Staphylococcus aureus in a pharmacodynamic model.
    Allen GP; Kaatz GW; Rybak MJ
    Int J Antimicrob Agents; 2004 Aug; 24(2):150-60. PubMed ID: 15288314
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel structural analogues of piperine as inhibitors of the NorA efflux pump of Staphylococcus aureus.
    Kumar A; Khan IA; Koul S; Koul JL; Taneja SC; Ali I; Ali F; Sharma S; Mirza ZM; Kumar M; Sangwan PL; Gupta P; Thota N; Qazi GN
    J Antimicrob Chemother; 2008 Jun; 61(6):1270-6. PubMed ID: 18334493
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quinolone resistance mediated by norA: physiologic characterization and relationship to flqB, a quinolone resistance locus on the Staphylococcus aureus chromosome.
    Ng EY; Trucksis M; Hooper DC
    Antimicrob Agents Chemother; 1994 Jun; 38(6):1345-55. PubMed ID: 8092836
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evolution from a natural flavones nucleus to obtain 2-(4-Propoxyphenyl)quinoline derivatives as potent inhibitors of the S. aureus NorA efflux pump.
    Sabatini S; Gosetto F; Manfroni G; Tabarrini O; Kaatz GW; Patel D; Cecchetti V
    J Med Chem; 2011 Aug; 54(16):5722-36. PubMed ID: 21751791
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Capsaicin, a novel inhibitor of the NorA efflux pump, reduces the intracellular invasion of Staphylococcus aureus.
    Kalia NP; Mahajan P; Mehra R; Nargotra A; Sharma JP; Koul S; Khan IA
    J Antimicrob Chemother; 2012 Oct; 67(10):2401-8. PubMed ID: 22807321
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of the effect of bacterial efflux pumps on the antibacterial activity of the novel fluoroquinolone besifloxacin.
    Shinabarger DL; Zurenko GE; Hesje CK; Sanfilippo CM; Morris TW; Haas W
    J Chemother; 2011 Apr; 23(2):80-6. PubMed ID: 21571623
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Optimized efflux assay for the NorA multidrug efflux pump in Staphylococcus aureus.
    Zimmermann S; Tuchscherr L; Rödel J; Löffler B; Bohnert JA
    J Microbiol Methods; 2017 Nov; 142():39-40. PubMed ID: 28887002
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phenothiazines and thioxanthenes inhibit multidrug efflux pump activity in Staphylococcus aureus.
    Kaatz GW; Moudgal VV; Seo SM; Kristiansen JE
    Antimicrob Agents Chemother; 2003 Feb; 47(2):719-26. PubMed ID: 12543683
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Susceptibility and resistance genes to fluoroquinolones in methicillin-resistant Staphylococcus aureus isolated in 2002.
    Noguchi N; Okihara T; Namiki Y; Kumaki Y; Yamanaka Y; Koyama M; Wakasugi K; Sasatsu M
    Int J Antimicrob Agents; 2005 May; 25(5):374-9. PubMed ID: 15848290
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Functionalization of ZnO Nanoparticles by Glutamic Acid and Conjugation with Thiosemicarbazide Alters Expression of Efflux Pump Genes in Multiple Drug-Resistant
    Nejabatdoust A; Zamani H; Salehzadeh A
    Microb Drug Resist; 2019 Sep; 25(7):966-974. PubMed ID: 30855211
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis of amides from (E)-3-(1-chloro-3,4-dihydronaphthalen-2-yl)acrylic acid and substituted amino acid esters as NorA efflux pump inhibitors of Staphylococcus aureus.
    Rath SK; Singh S; Kumar S; Wani NA; Rai R; Koul S; Khan IA; Sangwan PL
    Bioorg Med Chem; 2019 Jan; 27(2):343-353. PubMed ID: 30552006
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Frequency and genetic characterization of multidrug-resistant mutants of Staphylococcus aureus after selection with individual antiseptics and fluoroquinolones.
    Noguchi N; Tamura M; Narui K; Wakasugi K; Sasatsu M
    Biol Pharm Bull; 2002 Sep; 25(9):1129-32. PubMed ID: 12230102
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.